Oyster Point Pharma, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2021

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Oyster Point Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2021.
  • Oyster Point Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$36.7M, a 108% decline year-over-year.
  • Oyster Point Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$177M, a 119% decline year-over-year.
  • Oyster Point Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$101M, a 42.7% decline from 2020.
  • Oyster Point Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$70.5M, a 54.3% decline from 2019.
  • Oyster Point Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was -$45.7M, a 177% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$101M -$30.1M -42.7% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-24
2020 -$70.5M -$24.8M -54.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$45.7M -$29.2M -177% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-18
2018 -$16.5M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.